Episode Details

Back to Episodes

#130 - TCM's Biggest Debates: Dry Needling, Cultural Appropriation & AI

Published 8 hours ago
Description

💌 Sign up for my FREE weekly newsletter where I share exclusive content I don't share anywhere else.

Okay, so today's a little bit different, and honestly, I'm a little bit nervous.

In this episode, for the first time ever, I am discussing the biggest debates in the TCM world: dry needling vs acupuncture, cultural appropriation in Chinese medicine, and whether AI could replace practitioners. 

My goal is not to tell you what to think. My goal is to just get us talking and understand each other behind these debates while encouraging thoughtful, open-minded dialogue.

In this episode, you’ll learn:
• The key differences between dry needling and acupuncture, including training, philosophy, and treatment approach
• Why treating the whole person matters beyond symptom relief and trigger points
• A thoughtful perspective on cultural appropriation, respect, and honouring TCM’s Chinese roots
• How AI tools can support research, learning, and clinic systems, without replacing human connection and clinical reasoning

Whether you strongly agree, disagree, or are still forming your opinion, this episode invites deeper reflection on the future of Chinese medicine and modern practice 💜

☯️ More AcuPro Episodes you'll love:

➡️ Visit the show notes for all the links mentioned in this episode!

Also, if you haven’t done so already, follow the podcast. So many fantastic episodes are coming your way! If you’re not following, there’s a good chance you’ll miss out.

🩵 This episode is brought to you by Jane, the practice management software I use in my clinic. It’s been a total game-changer for keeping scheduling, charting, and everything running smoothly.

Check it out here, and use my code ACUPRO1MO for a one-month grace period on your new account! 💜

And connect with @AcuProAcademy on all social media!

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us